HMS (HMSY) Now Covered by Chardan Capital
Stock analysts at Chardan Capital began coverage on shares of HMS (NASDAQ:HMSY) in a research note issued on Thursday, MarketBeat.com reports. The brokerage set a “neutral” rating and a $35.00 price target on the business services provider’s stock. Chardan Capital’s price target indicates a potential upside of 3.67% from the stock’s current price.
HMSY has been the topic of a number of other research reports. Robert W. Baird reaffirmed a “buy” rating and set a $30.00 target price on shares of HMS in a research note on Friday, August 3rd. Zacks Investment Research raised shares of HMS from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a research note on Saturday, June 9th. ValuEngine raised shares of HMS from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 13th. Leerink Swann initiated coverage on shares of HMS in a research note on Thursday, June 14th. They set an “outperform” rating and a $25.00 target price on the stock. Finally, Citigroup boosted their target price on shares of HMS from $21.00 to $25.00 and gave the stock a “neutral” rating in a research note on Friday, July 13th. Three analysts have rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $30.90.
NASDAQ HMSY opened at $33.76 on Thursday. The firm has a market cap of $2.79 billion, a price-to-earnings ratio of 78.51, a P/E/G ratio of 4.00 and a beta of 1.13. HMS has a fifty-two week low of $11.01 and a fifty-two week high of $33.85. The company has a current ratio of 3.87, a quick ratio of 3.87 and a debt-to-equity ratio of 0.39.
In other news, Chairman William C. Lucia sold 69,818 shares of HMS stock in a transaction on Thursday, July 12th. The shares were sold at an average price of $24.05, for a total transaction of $1,679,122.90. Following the transaction, the chairman now owns 181,400 shares in the company, valued at $4,362,670. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 3.20% of the stock is currently owned by insiders.
Several large investors have recently modified their holdings of HMSY. Millennium Management LLC lifted its holdings in shares of HMS by 278.2% during the first quarter. Millennium Management LLC now owns 1,289,484 shares of the business services provider’s stock worth $21,715,000 after purchasing an additional 948,541 shares during the period. BlackRock Inc. lifted its holdings in shares of HMS by 7.0% during the second quarter. BlackRock Inc. now owns 11,583,749 shares of the business services provider’s stock worth $250,443,000 after purchasing an additional 759,265 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of HMS by 40.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 1,007,174 shares of the business services provider’s stock worth $16,961,000 after purchasing an additional 292,456 shares during the period. Citadel Advisors LLC lifted its holdings in shares of HMS by 135.6% during the second quarter. Citadel Advisors LLC now owns 503,899 shares of the business services provider’s stock worth $10,895,000 after purchasing an additional 290,017 shares during the period. Finally, Standard Life Aberdeen plc lifted its holdings in HMS by 34.2% in the second quarter. Standard Life Aberdeen plc now owns 1,060,125 shares of the business services provider’s stock valued at $22,915,000 after buying an additional 269,878 shares during the period. Institutional investors own 96.16% of the company’s stock.
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.